UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. ________ )*
EP MedSystems, Inc.
--------------------------
(Name of Issuer)
Common Stock
----------------------------------
(Title of Class of Securities)
26881-P-103
-----------------------------------
(CUSIP Number)
Edwin K. Hunter
1807 Lake St.
Lake Charles, LA 70601-5771
(318)436-1600
------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is subject of this Schedule
13D, and is filing this schedule because of Rule 13d-1(b)(3) or
(4), check the following box [ ].
Check the following box if a fee is being paid with this
statement X . (A fee is not required only if the filing
person: (1) has a previous statement on file reporting
beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent
or less of such class.) (See Rule 13d-7).
* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 26881-P-103 13D Page 2 of 4 Pages
1 NAME OF REPORTING PERSON Edwin K. Hunter
S.S. OR I.R.S. ID NO. OF ABOVE PERSON
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A (a)
GROUP (b)
3 SEC USE ONLY
4 SOURCE OF FUNDS PF
5 CHECK BOX IF DISCLOSURE OF LEGAL
PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS [ ]
2(d) or 2(e).
6 CITIZENSHIP OR PLACE OF ORGANIZATION United States
Citizen
NUMBER OF 7 SOLE VOTING POWER 194,500 shares
SHARES
BENEFICIALLY 8 SHARED VOTING POWER 310,000 shares
OWNED BY
EACH 9 SOLE DISPOSITIVE POWER 194,500 shares
REPORTING
PERSON 10 SHARED DISPOSITIVE POWER 310,000 shares
WITH
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY
EACH REPORTING PERSON 504,500 shares
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW
(11) EXCLUDES CERTAIN SHARES
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN 6.6%
ROW 11
12 TYPE OF REPORTING PERSON IN
CUSIP No. 26881-P-103 13D Page 2 of 4
Pages
ITEM 1. SECURITY AND ISSUER
(a) Name of Issuer EP MedSystems, Inc.
(b) Class of equity security Common Stock
(c) Address of Issuer's Principal Executive Offices
58 Route 46 West
Budd Lake, NJ 07828
ITEM 2. IDENTITY AND BACKGROUND
(a) Name of Person Filing Edwin K. Hunter
(b) Address of Principal Business Office
1807 Lake Street
Lake Charles, LA 70601-5771
(c) Present Principal Occupation Attorney
Hunter, Blazer, O'Dowd & Moreno
1807 Lake Street
Lake Charles, LA 70601-5771
(d) Not Applicable
(e) Not Applicable
(f) Citizenship United States Citizen
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The funds used to purchase all shares were from existing cash reserves.
ITEM 4. PURPOSE OF TRANSACTION
The securities were acquired for long term investment purposes.
(a) Not applicable
(b) Not applicable
(c) Not applicable
(d) Not applicable
(e) Not applicable
(f) Not applicable
(g) Not applicable
(h) Not applicable
(i) Not applicable
(j) Not applicable
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) Amount Beneficially Owned 504,500 shares
Percent of Class 6.6%
(b) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote 194,500 shares
(ii) shares power to vote or to direct the vote 310,000 shares
(iii) sole power to dispose or to direct the disposition of 194,500 shares
(iv) shared power to dispose or to direct the disposition of 310,000 shares
(c) An aggregate of 162,500 shares were acquired upon the
exercise of warrants. The warrants were exercised in connection
with the repayment by EP MedSystems, Inc. of its 1995 Debentures.
The warrant was to expire within 30 days of such repayment.
The aggregate consideration for the 162,500 shares was $325,000
or $2.00 per share.
(d) Not applicable
(e) Not applicable
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR
RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
Not Applicable
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in
this statement is true, complete and correct.
February 13, 1997 /s/ Edwin K. Hunter
- ----------------- --------------------
Date Signature
Edwin K.Hunter
-----------------
Name
